Synopsis
Synopsis
0
KDMF
0
VMF
Annual Reports
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers


1. L 705,126
2. L 705126
3. L-705,126
4. L-705126
5. Maxalt
6. Mk 0462
7. Mk 462
8. Mk-0462
9. Mk-462
10. N,n-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indole-3-yl)ethylamine
11. Rizatriptan
1. 145202-66-0
2. Maxalt
3. Rizatriptan (benzoate)
4. Maxalt-mlt
5. Mk 462
6. Mk-462
7. Mk-0462
8. 2-(5-((1h-1,2,4-triazol-1-yl)methyl)-1h-indol-3-yl)-n,n-dimethylethanamine Benzoate
9. Nsc-758919
10. Wr978s7qhh
11. Rizatriptan Benzoate (maxalt)
12. N,n-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl]ethylamine Benzoate
13. 3-(2-(dimethylamino)ethyl)-5-(1h-1,2,4-triazol-1-ylmethyl)indole Monobenzoate
14. 1h-indole-3-ethanamine, N,n-dimethyl-5-(1h-1,2,4-triazol-1-ylmethyl)-, Monobenzoate
15. 2-(5-((1h-1,2,4-triazol-1-yl)methyl)-1h-indol-3-yl)-n,n-dimethylethan-1-amine Benzoate
16. Benzoic Acid;n,n-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl]ethanamine
17. Rizatriptanbenzoate
18. N,n-dimethyl-5-(1h-1,2,4-triazol-1-ylmethyl)-1h-indole-3-ethanamine Benzoate
19. Rizatriptan Benzoate [usan]
20. Mk 0462
21. Unii-wr978s7qhh
22. L 705126
23. L 705,126
24. L-705,126
25. Rizatriptan Benzoate [usan:usp]
26. Rizatrimptan Benzoate
27. Rizatriptane Benzoate
28. Rizatriptan, Benzoate
29. Mk-462 Benzoate
30. Schembl41226
31. Mls001424197
32. Chebi:8875
33. Rizatriptan Benzoate Salt
34. Chembl1201032
35. Rizatriptan Benzoate (jan/usp)
36. Amy8935
37. Dtxsid20162937
38. Rhb-103
39. Rizatriptan Benzoate [mi]
40. Hms2051b16
41. Hms2093k08
42. Hms2235m18
43. Hms3369i15
44. Hms3393b16
45. Hms3655k09
46. Hms3715d08
47. Hms3884k21
48. Pharmakon1600-01505189
49. Rizatriptan Benzoate [jan]
50. Act04340
51. Bcp02149
52. Hy-b0206
53. Int-0008
54. Rizatriptan Benzoate [vandf]
55. Ac-734
56. Mfcd00866224
57. Nsc758919
58. Rizatriptan Benzoate [mart.]
59. Rizatriptan Benzoate [usp-rs]
60. Rizatriptan Benzoate [who-dd]
61. Akos015855933
62. Ab07521
63. Ccg-101039
64. Ks-1189
65. Nc00289
66. Nsc 758919
67. Rizatriptan Benzoate [orange Book]
68. Smr000525252
69. Rizatriptan Benzoate [ep Monograph]
70. Db-015783
71. Rizatriptan Benzoate [usp Monograph]
72. Rizatriptan Benzoate Salt, >=98% (hplc)
73. Ft-0631171
74. R0107
75. R0181
76. S1607
77. Sw197669-2
78. D00675
79. 202r660
80. A808337
81. Sr-01000763588
82. J-008071
83. J-524222
84. Sr-01000763588-3
85. Q27292788
86. Rizatriptan Benzoate, European Pharmacopoeia (ep) Reference Standard
87. Rizatriptan Benzoate, United States Pharmacopeia (usp) Reference Standard
88. Dimethyl-[2-(5-[1,2,4]triazol-1-ylmethyl-1h-indol-3-yl)-ethyl]-amine Benzoate
89. N,n-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl]ethanamine Benzoate
90. Rizatriptan For System Suitability, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 391.5 g/mol |
|---|---|
| Molecular Formula | C22H25N5O2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 391.20082506 g/mol |
| Monoisotopic Mass | 391.20082506 g/mol |
| Topological Polar Surface Area | 87 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 412 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Maxalt |
| PubMed Health | Rizatriptan (By mouth) |
| Drug Classes | Antimigraine |
| Drug Label | MAXALTCOPYRIGHT 1998, 2006 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.All rights reserved contains rizatriptan benzoate, a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist.Rizatriptan benzoate is described chemical |
| Active Ingredient | Rizatriptan benzoate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 5mg base; eq 10mg base |
| Market Status | Prescription |
| Company | Merck |
| 2 of 4 | |
|---|---|
| Drug Name | Rizatriptan benzoate |
| Drug Label | MAXALTCOPYRIGHT 1998, 2006 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.All rights reserved contains rizatriptan benzoate, a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist.Rizatriptan benzoate is described chemical |
| Active Ingredient | Rizatriptan benzoate |
| Dosage Form | Tablet; Tablet, orally disintegrating |
| Route | Oral |
| Strength | eq 5mg base; eq 10mg base |
| Market Status | Prescription |
| Company | Mylan Pharms; Apotex; Aurobindo Pharma; Natco Pharma; Sandoz; Invagen Pharms; Cipla; Sun Pharma Global; Glenmark Generics; Emcure Pharms; Teva Pharms; Macleods Pharms |
| 3 of 4 | |
|---|---|
| Drug Name | Maxalt |
| PubMed Health | Rizatriptan (By mouth) |
| Drug Classes | Antimigraine |
| Drug Label | MAXALTCOPYRIGHT 1998, 2006 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.All rights reserved contains rizatriptan benzoate, a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist.Rizatriptan benzoate is described chemical |
| Active Ingredient | Rizatriptan benzoate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 5mg base; eq 10mg base |
| Market Status | Prescription |
| Company | Merck |
| 4 of 4 | |
|---|---|
| Drug Name | Rizatriptan benzoate |
| Drug Label | MAXALTCOPYRIGHT 1998, 2006 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.All rights reserved contains rizatriptan benzoate, a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist.Rizatriptan benzoate is described chemical |
| Active Ingredient | Rizatriptan benzoate |
| Dosage Form | Tablet; Tablet, orally disintegrating |
| Route | Oral |
| Strength | eq 5mg base; eq 10mg base |
| Market Status | Prescription |
| Company | Mylan Pharms; Apotex; Aurobindo Pharma; Natco Pharma; Sandoz; Invagen Pharms; Cipla; Sun Pharma Global; Glenmark Generics; Emcure Pharms; Teva Pharms; Macleods Pharms |
Serotonin Receptor Agonists
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : RIZATRIPTAN BENZOATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Approval Date : 2016-02-18
Application Number : 203269
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : RIZATRIPTAN BENZOATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Approval Date : 2012-12-31
Application Number : 202244
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : RIZATRIPTAN BENZOATE
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : EQ 10MG BASE
Approval Date : 2013-07-01
Application Number : 203062
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : RIZATRIPTAN BENZOATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Approval Date : 2013-03-26
Application Number : 77526
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : RIZATRIPTAN BENZOATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Approval Date : 2013-07-01
Application Number : 204339
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : RIZATRIPTAN BENZOATE
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : EQ 5MG BASE
Approval Date : 2015-10-16
Application Number : 203334
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : RIZATRIPTAN BENZOATE
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : EQ 5MG BASE
Approval Date : 2014-09-19
Application Number : 203146
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : RIZATRIPTAN BENZOATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 5MG BASE
Approval Date : 2012-12-31
Application Number : 200482
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : RIZATRIPTAN BENZOATE
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : EQ 5MG BASE
Approval Date : 2017-01-11
Application Number : 204722
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : RIZATRIPTAN BENZOATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Approval Date : 2012-12-31
Application Number : 79230
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rizatriptan Flas Pensa
Dosage Form : Orodispersible Tablet
Dosage Strength : 10MG
Packaging :
Approval Date : 2013-02-01
Application Number : 77083
Regulatory Info : Authorized
Registration Country : Spain
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Italy
Brand Name : RIZATRIPTAN DOC
Dosage Form : Orodispersible Tablets
Dosage Strength : 10 mg
Packaging : 3 UNITS 10 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Rizatriptan Glenmark
Dosage Form : Orodispersible Tablet
Dosage Strength : 5mg
Packaging :
Approval Date : 15/12/2011
Application Number : 20100424000045
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rizatriptan Flas Kern Pharma
Dosage Form : Orodispersible Tablet
Dosage Strength : 10MG
Packaging :
Approval Date : 2013-02-01
Application Number : 77082
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Italy
Brand Name : Maxalt Rpd Liof
Dosage Form : Rizatriptan 10Mg 3 Units' Oral Use
Dosage Strength : 3 os liof 10 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Norway
Brand Name : Maxalt Rapitab
Dosage Form : Melting tablet
Dosage Strength : 10 mg
Packaging : Endose blister pack 3 1item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Maxalt Max
Dosage Form : Oral Lyophilized
Dosage Strength : 10MG
Packaging :
Approval Date : 2023-02-24
Application Number : 3400934794346IP1
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Rizatriptan Teva
Dosage Form : Orodispersible Tablet
Dosage Strength : 5mg
Packaging :
Approval Date : 26/02/2010
Application Number : 20090203000031
Regulatory Info : Deregistered
Registration Country : Sweden

Regulatory Info :
Registration Country : Italy
Brand Name : Trizadol Rpd Liof
Dosage Form : Rizatriptan 10Mg 3 Units' Oral Use
Dosage Strength : 3 os liof 10 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Maxalt Rapitab
Dosage Form : Tablet
Dosage Strength : 10 mg
Packaging : Blister, endose
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
Brand Name : ACCEL-RIZATRIPTAN ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 10MG
Packaging : 6
Approval Date :
Application Number : 2483289
Regulatory Info : Prescription
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
Brand Name : MAR-RIZATRIPTAN
Dosage Form : TABLET
Dosage Strength : 10MG
Packaging : 6/12/30/100/500
Approval Date :
Application Number : 2379678
Regulatory Info : Prescription
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
Brand Name : MAR-RIZATRIPTAN ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 10MG
Packaging : 6
Approval Date :
Application Number : 2462796
Regulatory Info : Prescription
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
Brand Name : NAT-RIZATRIPTAN ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 5MG
Packaging : 6
Approval Date :
Application Number : 2436604
Regulatory Info : Prescription
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : PMS-RIZATRIPTAN RDT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 10MG
Packaging : 11121
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
Brand Name : PMS-RIZATRIPTAN RDT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 10MG
Packaging : 06/12/1930
Approval Date :
Application Number : 2393379
Regulatory Info : Prescription
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
Brand Name : SANDOZ RIZATRIPTAN ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 5MG
Packaging : 6
Approval Date :
Application Number : 2351870
Regulatory Info : Prescription
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
Brand Name : RIZATRIPTAN
Dosage Form : TABLET
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number : 2516756
Regulatory Info : Prescription
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
Brand Name : RIZATRIPTAN ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 5MG
Packaging : 6
Approval Date :
Application Number : 2446111
Regulatory Info : Prescription
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Canada
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
Brand Name : TEVA-RIZATRIPTAN ODT
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 10MG
Packaging : 06-Oct
Approval Date :
Application Number : 2396688
Regulatory Info : Prescription
Registration Country : Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : Rizatriptan Wafers-10mg
Dosage Form :
Dosage Strength : 10 mg
Packaging : 2
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : Maxalt
Dosage Form :
Dosage Strength : 10 mg
Packaging : 2
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : Rizatriptan ODT APOTEX
Dosage Form :
Dosage Strength :
Packaging : 2
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : APO-RIZATRIPTAN ODT
Dosage Form :
Dosage Strength :
Packaging : 2
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : RIXALT
Dosage Form :
Dosage Strength :
Packaging : 2
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : Rizatriptan-Au
Dosage Form :
Dosage Strength :
Packaging : 2
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

Regulatory Info :
Registration Country : Australia
Brand Name : RIZATRIPTAN ODT-WGR
Dosage Form :
Dosage Strength :
Packaging : 2
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
41
PharmaCompass offers a list of Rizatriptan Benzoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rizatriptan Benzoate manufacturer or Rizatriptan Benzoate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rizatriptan Benzoate manufacturer or Rizatriptan Benzoate supplier.
PharmaCompass also assists you with knowing the Rizatriptan Benzoate API Price utilized in the formulation of products. Rizatriptan Benzoate API Price is not always fixed or binding as the Rizatriptan Benzoate Price is obtained through a variety of data sources. The Rizatriptan Benzoate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rizatriptan (benzoate) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rizatriptan (benzoate), including repackagers and relabelers. The FDA regulates Rizatriptan (benzoate) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rizatriptan (benzoate) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rizatriptan (benzoate) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rizatriptan (benzoate) supplier is an individual or a company that provides Rizatriptan (benzoate) active pharmaceutical ingredient (API) or Rizatriptan (benzoate) finished formulations upon request. The Rizatriptan (benzoate) suppliers may include Rizatriptan (benzoate) API manufacturers, exporters, distributors and traders.
click here to find a list of Rizatriptan (benzoate) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rizatriptan (benzoate) DMF (Drug Master File) is a document detailing the whole manufacturing process of Rizatriptan (benzoate) active pharmaceutical ingredient (API) in detail. Different forms of Rizatriptan (benzoate) DMFs exist exist since differing nations have different regulations, such as Rizatriptan (benzoate) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rizatriptan (benzoate) DMF submitted to regulatory agencies in the US is known as a USDMF. Rizatriptan (benzoate) USDMF includes data on Rizatriptan (benzoate)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rizatriptan (benzoate) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rizatriptan (benzoate) suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Rizatriptan (benzoate) Drug Master File in Japan (Rizatriptan (benzoate) JDMF) empowers Rizatriptan (benzoate) API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Rizatriptan (benzoate) JDMF during the approval evaluation for pharmaceutical products. At the time of Rizatriptan (benzoate) JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Rizatriptan (benzoate) suppliers with JDMF on PharmaCompass.
A Rizatriptan (benzoate) CEP of the European Pharmacopoeia monograph is often referred to as a Rizatriptan (benzoate) Certificate of Suitability (COS). The purpose of a Rizatriptan (benzoate) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Rizatriptan (benzoate) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Rizatriptan (benzoate) to their clients by showing that a Rizatriptan (benzoate) CEP has been issued for it. The manufacturer submits a Rizatriptan (benzoate) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Rizatriptan (benzoate) CEP holder for the record. Additionally, the data presented in the Rizatriptan (benzoate) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Rizatriptan (benzoate) DMF.
A Rizatriptan (benzoate) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Rizatriptan (benzoate) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Rizatriptan (benzoate) suppliers with CEP (COS) on PharmaCompass.
A Rizatriptan (benzoate) written confirmation (Rizatriptan (benzoate) WC) is an official document issued by a regulatory agency to a Rizatriptan (benzoate) manufacturer, verifying that the manufacturing facility of a Rizatriptan (benzoate) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rizatriptan (benzoate) APIs or Rizatriptan (benzoate) finished pharmaceutical products to another nation, regulatory agencies frequently require a Rizatriptan (benzoate) WC (written confirmation) as part of the regulatory process.
click here to find a list of Rizatriptan (benzoate) suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rizatriptan (benzoate) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rizatriptan (benzoate) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rizatriptan (benzoate) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rizatriptan (benzoate) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rizatriptan (benzoate) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rizatriptan (benzoate) suppliers with NDC on PharmaCompass.
Rizatriptan (benzoate) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rizatriptan (benzoate) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rizatriptan (benzoate) GMP manufacturer or Rizatriptan (benzoate) GMP API supplier for your needs.
A Rizatriptan (benzoate) CoA (Certificate of Analysis) is a formal document that attests to Rizatriptan (benzoate)'s compliance with Rizatriptan (benzoate) specifications and serves as a tool for batch-level quality control.
Rizatriptan (benzoate) CoA mostly includes findings from lab analyses of a specific batch. For each Rizatriptan (benzoate) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rizatriptan (benzoate) may be tested according to a variety of international standards, such as European Pharmacopoeia (Rizatriptan (benzoate) EP), Rizatriptan (benzoate) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rizatriptan (benzoate) USP).